2024

1. C-reactive Protein and Risk of Right Ventricular Dysfunction and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

   Archivos de Bronconeumologia, Vol. 60, Núm. 6, pp. 344-349

2. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

   Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

3. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

   Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

4. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review

   Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 6, pp. 851-865

5. External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry

   Thrombosis Research, Vol. 235, pp. 22-31

6. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications

   Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 5, pp. 773-789

7. High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients with Acute Pulmonary Embolism

   JAMA Cardiology, Vol. 9, Núm. 1, pp. 64-70

8. International Clinical Practice Guideline Recommendations for Acute Pulmonary Embolism: Harmony, Dissonance, and Silence

   Journal of the American College of Cardiology, Vol. 84, Núm. 16, pp. 1561-1577

9. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

   Nature Reviews Cardiology, Vol. 21, Núm. 8, pp. 574-592

10. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial

    Chest, Vol. 165, Núm. 3, pp. 673-681

11. Prognostic significance of saddle pulmonary embolism a post hoc analysis of the PROTECT cohort study

    Thrombosis Research

12. Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: What is the best strategy for clinicians?

    Current Opinion in Pulmonary Medicine

13. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

14. Response

    Chest

15. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

    eClinicalMedicine, Vol. 73

16. Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis

    European Heart Journal, Vol. 45, Núm. 32, pp. 2933-2950

17. Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism

    Thrombosis Research, Vol. 233, pp. 18-24

18. Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry

    Thrombosis Research, Vol. 236, pp. 88-96

19. The prognostic value of blood cellular indices in pulmonary embolism

    American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711

20. Time to Resolution of Right Ventricle Dysfunction in Patients With Acute Pulmonary Embolism

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 448-450